Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban PK/PD in Nephrotic Syndrome
NCT07116239Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
01
Overview
Open-label trial of edoxaban in nephrotic syndrome (5 arms), sponsored by Peking University People's Hospital. Primary endpoints: Area Under the Steady-state Plasma Concentration-time Curve at Day 4, Time to Peak Concentration at Day 4 and 13 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT07116239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116239.